REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
09/22/2025
Back to search
Official data from USPTO
PLEXZYME
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PLEXZYME
ST13
US500000079270028Class
42, 44
Filing
79270028
Registration
6155742
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
09/23/2025
Trademark type
Word
Nice classes
42, 44
Filing date
06/17/2019
Registration date
09/22/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/22/2020
Last transaction
09/23/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
82
Owner location
EVELEIGH NSW 2015, AU
Examiner
MESSICK, TABITHA
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
SpeeDx Pty Ltd
SpeeDx Pty Ltd
Representatives
Joi A. White Carr & Ferrell LLP
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Scientific and technological services and research and design relating theretoDNA analysis services for scientific research purposesscientific research consulting in the field of genetics; genetic research; genetic engineering services; scientific research in the field of genetics and genetic engineering; scientific research relating to genetics; chemistry serviceschemistry research services; research relating to chemistry; scientific research relating to chemistry; research in the field of chemistry; laboratory analysis in the field of chemistry; development of medical diagnostic apparatus; design of medical diagnostic apparatus; research relating to molecular sciences; analysis of data generated by scientific and medical experiments and tests; biologicalbacteriologicalchemicalbiochemicalDNARNAproteinpolynucleic acid and molecular analysis and evaluation services for scientific testing and research purposes; DNA and RNA and polynucleic acid and protein sequencinganalysis and evaluation services for scientific testing and research purposes; genome sequencing services and the analysis and evaluation of data resulting therefrom for scientific testing and research purposes; scientific analysis and the provision of reports in conjunction therewith relating to scientific and medical experimentsrelating to the results of scientific and medical experiments and testsrelating to the analysis and evaluation of scientific and medical datarelating to data generated by scientific and medical experiments and tests; scientific and medical research and development services; custom design and development of biochemical assays
Class 44
Medical services; human healthcare services; medical testing services relating to the diagnosis and treatment of disease; genetic testing for medical purposes; medical and health services relating to DNAgenetics and genetic testing; medical diagnostic services in the nature of medical testing and medical analysis; molecular diagnostics testing for medical purposes; providing collected and analysed medical information in the field of genetic and treatment information for diseases and disorders for diagnostic and treatment purposes; medical diagnostic imaging and molecular medicine services
Publications
History of USPTO decisions and trademark events.
30 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/08/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/08/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/08/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/04/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/16/2021
FIMP
FINAL DISPOSITION PROCESSED
03/16/2021
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
03/16/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/22/2020
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
10/10/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
09/22/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/07/2020
PUBO
PUBLISHED FOR OPPOSITION
07/07/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/17/2020
ALIE
ASSIGNED TO LIE
06/04/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/28/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/18/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/17/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/17/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/19/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/19/2019
RFNT
REFUSAL PROCESSED BY IB
12/06/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/18/2019
RFRR
REFUSAL PROCESSED BY MPU
11/18/2019
MAFR
APPLICATION FILING RECEIPT MAILED
10/29/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/27/2019
CNRT
NON-FINAL ACTION WRITTEN
10/26/2019
DOCK
ASSIGNED TO EXAMINER
10/25/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/25/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/24/2019
Continuous trademark protection
Get notified about every new filing that threatens PLEXZYME or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.